Are Medical Stocks Lagging Akero Therapeutics (AKRO) This Year?

Company Performance - Akero Therapeutics, Inc. (AKRO) has shown a year-to-date performance increase of approximately 73.5%, significantly outperforming the average loss of 7.5% in the Medical sector [4] - The Zacks Consensus Estimate for AKRO's full-year earnings has increased by 1.4% over the past quarter, indicating improved analyst sentiment and a stronger earnings outlook [3] Industry Comparison - Akero Therapeutics, Inc. is part of the Medical - Biomedical and Genetics industry, which consists of 489 companies and currently ranks 141 in the Zacks Industry Rank. This industry has experienced a slight decline of about 0.9% year-to-date, further highlighting AKRO's superior performance [6] - In contrast, Aveanna Healthcare (AVAH), another outperforming stock in the Medical sector, belongs to the Medical - Outpatient and Home Healthcare industry, which has seen a year-to-date increase of 3.8% and ranks 40 [7]